Home › Funds › PSP Research LLC › LQDA

PSP Research LLC position in LQDA

LIQUIDIA CORPORATION · Health Care

PSP Research LLC reported holding 5,000 shares of LQDA (LIQUIDIA CORPORATION) in its Q2 2026 13F filing — a position valued at US$399K, representing 0.21% of its reported portfolio and ranking #35 among its reported holdings. PSP Research LLC has disclosed LQDA holdings in 2 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)5.00K sh
Reported value held$398.65K
Portfolio Weight0.21%
First reportedQ4 2025
Last changeNew

How PSP Research LLC's LQDA position evolved

PSP Research LLC first disclosed a stake in LQDA in Q4 2025 at 15,485 shares (US$534K). Across 2 filings, PSP Research LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 5,000 shares valued at US$399K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 15.48K $534.08K New
Q2 2026 5.00K $398.65K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LQDA and 13F data

LQDA (LIQUIDIA CORPORATION) is a Health Care company. 75 other funds we track also report a position in LQDA — the largest reported positions include Farallon Capital Management (US$666.9M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$666.9M), Caligan Partners LP (US$647.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LQDA

All LQDA fund holders →